Eli Lilly and Co. on Tuesday announced that it is buying New York-based Prevail Therapeutics Inc., an emerging player in the sizzling-hot area of gene therapies, which targets Parkinson’s disease and other brain-related maladies.
Lilly said it will enroll up to 500,000 people in its latest study, with at least 5,000 people expected to receive bamlanivimab therapy. The drugmaker is partnering with health insurer UnitedHealth Group to see if the drug will help high-risk people.
CEO Jeff Simmons said the company’s high-profile downtown Indianapolis headquarters will signal a cultural transformation at the company, which for most of its six decades of existence operated as a little-noticed subsidiary of Eli Lilly and Co.
In every significant statistical category, November has been a record-setter for the COVID-19 pandemic in Indiana, with cases, deaths and hospitalizations far exceeding even the early months of the coronavirus outbreak.
Despite the change in fortunes, Ascension signaled that it is not yet out of the woods, noting that “consumer confidence and healthcare hesitation as a result of COVID-19 continue to affect Ascension markets, to varying degrees.”
The not-for-profit launched in 2013 as a way to bridge the gap between research universities and industry in life sciences. But its report card so far is decidedly mixed, and it just hired its third CEO.
Under the Affordable Care Act, health insurers are required to spend 80% to 85% of the revenue they get from premiums on medical care. If they don’t, they have to issue rebates or credits to make up the difference.
The federal government says readmissions are often unnecessary and cost taxpayers tens of billions of dollars a year for treatments that should have been caught the first time around, or were not followed up adequately.
Indiana lags much of the nation in flu vaccination rates, and some public health officials say the combination of flu and coronavirus illness could overwhelm hospitals this winter.
State statistics reveal a very uneven, lumpy picture for COVID-19 cases from county to county, and the picture is constantly shifting.
A panel of experts spoke at IBJ’s Life Sciences Power Breakfast, which took place virtually Oct. 9, talked about venture capital in the life sciences sector. These are some excerpts.
It’s that time of year, when workers gather in the conference room (or through a zoom video conference) and brace for the latest news on health insurance plans.
The hospital system has filed a petition for vacation of several streets, meaning it wants to close or privatize them and fold them into the new campus.
The layoff is the first step in what is expected to be a major restructuring following Greenfield-based Elanco’s $6.9 billion acquisition of German conglomerate Bayer AG’s animal-health division.
Like many other providers, Ascension suspended all elective, nonessential medical and surgical procedures for several months to prepare for the surge of COVID-19 patients, reducing volume and revenue.
The joint-venture announcement by partners Community Health Network and Kindred Healthcare comes less than a month after the partners closed another rehabilitation hospital, Community Howard Specialty Hospital and Replay Physical Therapy in Kokomo.
Lilly and partner Boehringer Ingelheim published results from a trial showing the drug cut the risk of cardiovascular hospitalizations or death by 25%, compared to placebo in heart failure patients.
Starting Monday, the state began including positive results from antigen tests along with its traditional PCR tests. That single move reduced the state’s testing-positivity rate—but some officials say the accuracy of antigen testing is still widely unknown.
Advanced Penetration Technology LLC said London-based research laboratory Virology Research Services evaluated the anti-viral impact of the product and concluded it is a “highly effective formulation” against the coronavirus.
The availability of ICU beds has fallen in recent weeks as hospitals have deactivated hundreds of beds while the number of COVID-19 hospitalizations has climbed.
